Appeals court upholds FTC ruling against Impax Labs
There was more than enough evidence for the Federal Trade Commission to rule that Impax Laboratories accepted illegal payments to delay the entry of an opioid painkiller for more than two...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch